The maintenance of elevated parathormone (PTH) levels leads to hypercalcemia, hypophosphatemia, and reduced bone mass with increased risk of fractures, as well as vascular calcification, with an increased risk of cardiovascular events and graft dysfunction8. The gene discussed is PTH; the disease is Hypercalcemia.